Form 4: Macrogenics Director Edward Hurwitz Reports Stock Vesting
SEC Form 4 Filing
Director Edward Hurwitz reports the vesting of restricted stock units (RSUs) into common stock of Macrogenics Inc.
Summary
- Edward Hurwitz, a director of Macrogenics Inc. (MGNX), reported a transaction on May 20, 2024, where 4,500 restricted stock units (RSUs) vested into common stock.
- The RSUs were granted on May 31, 2023, and each RSU represents the right to receive one share of Macrogenics common stock.
- Following the transaction, Hurwitz directly owns 37,574 shares of Macrogenics common stock.
- The vesting occurred one day before the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock vesting, neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. Vesting of RSUs is a common form of equity compensation.
Stakeholder Impact
- The vesting of RSUs may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/31/2023 | The restricted stock unit (RSU) grant was approved by the Board of Directors. |
| 05/20/2024 | Restricted stock units (RSUs) vested. |
| 05/21/2024 | Issuer's 2024 Annual Meeting of Stockholders. |
| 05/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.